Registration Header


Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor


Facebook LinkedIn Twitter YouTube

Start Date:10 October 2018

Start Time:10am ET (New York)

Duration:60 minutes


Study protocols are increasingly complex with the need for extensive data collection despite complicated drug regimes. Patients may be deterred from taking part in a trial by the need for frequent travel to a clinical sites and around 30% of patients drop out before study completion, leading to data loss, and potential approval delays.

The new model for Direct to/from Patient and home health care allows visits to be conducted in a patient’s home which improves engagement.

Featured speakers will explore the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor, and how homecare can make a difference to patients’ ongoing participation, quality of life and comfort throughout the trial.

For more information visit


Kimberly Finn

VP Global Homecare & DTP US Services

Kimberly Finn is Vice President, Global Home Care and Direct to Patient US Services. She has extensive experience in the clinical trial industry having started her career as a CRA. Over the past 24 years, she assumed roles of increasing responsibility within clinical operations and global project management in both pharma and CRO organizations. Kimberly’s expertise in protocol design and clinical strategy has contributed to successful on-time delivery of complex portfolios valued at greater than $300M USD and she has directly contributed to the development of six NDA approved and marketed compounds.

Paddy Hanlon

VP Global Key Accounts

With over 30+ years’ experience in the healthcare and pharmaceutical clinical trial industry, Paddy is Vice President, Global Key Accounts at Marken with responsibility for the ongoing business needs of strategic clients including the delivery of drugs within time and in specifications, supply chain optimization and bringing innovation and solutions to clients. Prior to joining Marken worked at MDS Pharma Services with over a dozen years in provision of clinical trial services including central lab, ECG core lab and CRO services. Paddy’s career commenced in the healthcare industry, as hospital administrator and subsequently a director at Canada’s largest diagnostic laboratory, as a regional manager and director in their hospital strategy division. Paddy has a Masters in Health Science from the Facility of Family & Community Medicine at University of Toronto and a B.A. in Psychology.

Jennifer Fenwick

Director, Project Management, Americas

Jennifer Fenwick is Director, Project Management, for the Americas region with the responsibility of leading a growing team that manages DTP, distribution and logistics projects for Marken’s global clients. Jennifer has more than 10 years of experience in logistics having worked for major diagnostics and pharmaceutical companies on both the clinical and commercial sides of business. She joined Marken in September 2016 as a Project Manager and has seen first-hand the changing landscape in clinical trials. She understands the critical role DTP/DFP can play in getting drugs to market, and how Marken can fulfill the needs of our partners by offering best in class services and solutions.

First Name


Last Name
Job Title
Work Phone
Email Address
Got a burning question about this topic? Send it to us using the box below and we will try to have it answered by our expert panellists. You are also welcome to ask questions on the live day.

This Webinar is a free service provided to you by William Reed Business Media Ltd and this service is produced by Marken. Please let us know if you are happy for Marken to contact you about their products and services:

By Email:
By Phone:

William Reed Business Media Ltd. may use your contact data to keep you informed of its products and services by email or by phone. You can withdraw your marketing consent at any time by clicking the unsubscribe link in such email or by sending an email to

More information on our processing can be found in our Privacy Notice. By submitting this form, you acknowledge that you have read and understand our Privacy Notice